On December 31, Eli Lilly and (LLY) had a market capitalization of $693.1B, based on 903.16M shares at a price of $767.41.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2024 | $767.41 | 67,169,200 | 903,158,000 | $693,092,300,148.40 |
November 2024 | $790.62 | 99,593,100 | 903,158,000 | $714,055,590,802.20 |
October 2024 | $823.44 | 68,789,500 | 903,158,000 | $743,698,862,046.60 |
September 2024 | $879.22 | 58,008,800 | 905,000,000 | $795,690,661,000.00 |
August 2024 | $952.73 | 79,125,600 | 905,000,000 | $862,224,179,500.00 |
July 2024 | $797.05 | 72,471,200 | 905,000,000 | $721,332,331,500.00 |
June 2024 | $897.25 | 50,459,200 | 904,200,000 | $811,297,880,580.00 |
May 2024 | $812.98 | 58,803,000 | 904,200,000 | $735,094,798,020.00 |
April 2024 | $772.77 | 57,419,600 | 904,200,000 | $698,741,346,600.00 |
March 2024 | $769.67 | 58,751,800 | 903,800,000 | $695,624,582,700.00 |
February 2024 | $745.65 | 76,662,600 | 903,800,000 | $673,914,222,140.00 |
January 2024 | $637.61 | 61,985,100 | 903,800,000 | $576,271,737,240.00 |
December 2023 | $575.70 | 56,875,500 | 903,980,000 | $520,418,212,468.00 |
November 2023 | $583.72 | 75,604,900 | 903,980,000 | $527,667,589,680.00 |
October 2023 | $546.06 | 71,882,500 | 903,980,000 | $493,624,516,462.00 |
September 2023 | $529.50 | 58,012,700 | 949,303,000 | $502,651,856,497.10 |
August 2023 | $546.32 | 71,150,100 | 949,303,000 | $518,626,157,799.30 |
July 2023 | $447.13 | 46,828,200 | 949,303,000 | $424,462,799,693.00 |
June 2023 | $461.33 | 56,774,200 | 949,286,000 | $437,929,838,593.00 |
May 2023 | $422.45 | 75,450,200 | 949,286,000 | $401,026,345,343.00 |
April 2023 | $388.39 | 56,103,200 | 949,286,000 | $368,691,860,539.60 |
March 2023 | $336.94 | 80,114,100 | 949,267,000 | $319,844,504,152.80 |
February 2023 | $305.35 | 66,671,100 | 949,267,000 | $289,854,976,308.70 |
January 2023 | $336.57 | 50,722,700 | 949,267,000 | $319,490,712,341.90 |
December 2022 | $357.78 | 53,001,000 | 950,182,000 | $339,953,930,541.40 |
